Capital World Investors
ANAB icon

Capital World Investors’s AnaptysBio ANAB Stock Holding History

Capital World Investors’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,209,378
Closed -$42.3M – 517
2019
Q3 		$42.3M Hold
1,209,378
– – 0.01% 350
2019
Q2 		$68.2M Buy
1,209,378
+340,878
+39% +$24.5M 0.02% 322
2019
Q1 		$63.4M Hold
868,500
– – 0.02% 326
2018
Q4 		$55.4M Buy
868,500
+84,000
+11% +$6.25M 0.02% 333
2018
Q3 		$78.3M Buy
784,500
+397,500
+103% +$33M 0.02% 335
2018
Q2 		$27.5M Buy
387,000
+83,000
+27% +$6.96M 0.01% 429
2018
Q1 		$31.6M Buy
+304,000
New +$34.3M 0.01% 387

Other funds holding ANAB

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Capital World Investors's ANAB Position: Q4 2019 in Review

Capital World Investors sold out of AnaptysBio (ANAB) in Q4 2019, closing a stake of 1,209,378 shares — an estimated $42.3M sold.

Capital World Investors first reported a position in ANAB in Q1 2018 and held it in 7 quarters. The position peaked at $78.3M in Q3 2018. 121 funds tracked by Wall St. Rank hold ANAB as of Q4 2019.

  • Capital World Investors reported no remaining AnaptysBio position as of Q4 2019 after selling out during the quarter.
  • Capital World Investors sold 1,209,378 AnaptysBio shares in Q4 2019, an estimated $42.3M.
  • Capital World Investors first reported a position in AnaptysBio in Q1 2018 and held it in 7 quarters.
  • Capital World Investors's AnaptysBio position peaked at $78.3M in Q3 2018.
  • 121 funds tracked by Wall St. Rank held AnaptysBio as of Q4 2019.

Based on Capital World Investors's 13F filing for Q4 2019, filed 18 Feb 2020.